Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Aurora Cannabis

Canopy Growth

Cronos Group

HEXO Corp

With talk of a looming recession, analysts predict that given a downturn there will be a short list of growth industries capable of delivering a healthy return on investment.

5 Key Factors To Consider Before Making A Cannabis Acquisition

Aphria

CannTrust Holdings

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

GW Pharmaceuticals

Amplify Alternative Harvest ETF

Scotts Miracle-Gro

The week brought big cannabis news, with the FDA setting its first hearing regarding CBD's legality in food and drinks for May, and the STATES Act, which aims to protect cannabis businesses and users in legal states from federal intervention, being introduced in Congress.

This Week's Cannabis News: The FDA And CBD, The STATES Act, Cresco And Origin House, Europe And High Times

How should investors weigh Tilray's broad foundation against its high valuation?

Looking to Buy Tilray? 5 Things You Should Know First

Some very large transactions have sparked the cannabis sector lately, and I expect to see a lot more of this in the months ahead

Mergers And Acquisitions Light Up The Cannabis Sector

Hint: It's not the biggest of the big players.

Which Big Canadian Marijuana Stock Has the Most Upside Potential Right Now?

Sales are soaring, but so are operating losses for most pot stocks.

Marijuana Stock Earnings: A Comprehensive Look at First-Quarter Results

New Age Beverages

The cannabis space cooled down last month, due in part to a spate of quarterly earnings releases that failed to excite investors.

Why Marijuana Stocks Tilray, Cronos, and New Age Beverages Fell 10% to 19% in March

Insys Therapeutics

Despite a blazing hot start to the year, these pot stocks look to be buzzkills.

3 Marijuana Stocks to Avoid Like the Plague in April

While most cannabis stocks have had huge rallies so far in 2019, Tilray Inc. has been left in the dust.

Where Will Tilray's Stock Find Technical Support?

A ranking of the top marijuana growers by sales in the most recent quarter.

Here's Who Sold the Most Marijuana Last Quarter

The big Canadian marijuana stock dominated in the first quarter for three main reasons.

Why Aurora Cannabis Outperformed Canopy Growth and Tilray in Q1

Tilray Inc. shares dipped on Monday despite the cannabis firm announcing that it would be branching out and supporting two new clinical studies.

How Tilray Is Branching Out Its Business

Tilray, Inc. (NASDAQ: TLRY) announced its support of two clinical cannabis studies in Australia and Canada.

Tilray Announces Support Of 2 Clinical Studies In Australia, Canada

An industry worth $910 million in 2015 reached $13.8 billion in 2018, and it seems bound only sunward yet: The bottom line is, the sky’s the limit.

For Cannabis Industry Investment, 2018 Was Terrific But 2019 Looks Even Better

Two leaders, two laggards, and one in the group of top marijuana stocks that's most likely to succeed in the States.

Which Canadian Marijuana Stock Is Best Poised to Win in the U.S.: Aurora Cannabis, Cronos, Canopy Growth, or Tilray?

Is one of these two cannabis companies a better buy now?

Better Marijuana Stock to Buy: Tilray or Aurora Cannabis

Molson Coors Brewing

Despite a smaller consumer pool, focusing on medical cannabis has its advantages.

4 Reasons Medical Marijuana Stocks Are a Smarter Play Than Recreational Pot Stocks

The results are in -- and it's clear who the winners are so far in Canada's recreational marijuana market.

Canadian Recreational Pot Market: How the Big 5 Marijuana Growers Compare

If you think it'll be up, up, and away for pot stocks, you're probably in for an unpleasant surprise.

5 Off-the-Cuff Thoughts About the Marijuana Industry

It’s that time again. The Benzinga Events team is busy planning for the third Cannabis Capital Conference back in one of our favorite spots and the heart of the cannabis industry—Toronto.

Preparing For Toronto: Cannabis LP Executives To Talk About The Canadian Market

The vote for the SAFE Banking Act adds to the marijuana industry's momentum in Washington since November. 
The post Marijuana Stocks Edge Closer To Removing Huge U.S. Obstacle appeared first on Investor's Business Daily.

Marijuana Stocks Edge Closer To Removing Huge U.S. Obstacle

Cannabis stocks had a huge showing on Wall Street this past fall. In fact, most of the news flow surrounding these stocks had investors pouring money into them.

Short Sellers Hazy on Cannabis Stocks

Investors will have to wait until 2021 for any shot at profitability with this marijuana stock.

Which Pot Stock -- Aurora, Canopy, Tilray, or Cronos -- Will Be Profitable Last?

Say goodbye to a generalized excise tax on alternative consumption options.

A Big Change Is on the Way for Canada's Marijuana Excise Tax

According to Wall Street, the choice is pretty simple.

News for Tilray Brands Stock (TLRY)